{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:15:38Z","timestamp":1779207338100,"version":"3.51.4"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"38","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Rationale:<\/jats:title>\n                    <jats:p>\n                      Cardiac amyloidosis, considered for the last years to be a rare disease, is one of the determinants of HFpEF. The non-specific clinical presentation and the difficulties related to endomyocardial biopsy have made cardiac amyloidosis an underdiagnosed clinical entity. Improvement of non-invasive diagnostic techniques and the development of new therapies increased clinical awareness for this form of restrictive cardiomyopathy. We here summarize echocardiography and\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-HDP scintigraphy findings in 6 cases of cardiac amyloidosis and review the literature data of this progressive and fatal cardiomyopathy.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients concerns:<\/jats:title>\n                    <jats:p>The main clinical manifestations were fatigue, low exercise tolerance and edemas. The right heart failure symptoms usually dominated the clinical picture.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnoses:<\/jats:title>\n                    <jats:p>\n                      All cases were evaluated by echocardiography; 3 cases were further examined by bone scintigraphy and 4 cases a peripheral biopsy was performed. Electrocardiography showed low-voltage QRS complexes and \u201cpseudo-infarct\u201d pattern in the precordial leads, contrary to the echocardiographic aspect, which revealed thickening of ventricle walls. Biatrial dilation and diastolic disfunction were observed. Impaired systolic function was detected in advanced stages of the disease.\n                      <jats:sup>99m<\/jats:sup>\n                      Tc-HDP scintigraphy revealed cardiac uptake of radiopharmaceutical and managed to confirm the diagnosis in 1 case of cardiac amyloidosis in which salivary gland biopsy was negative.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions:<\/jats:title>\n                    <jats:p>The treatment was based on managing fluid balance, with the mainstream therapy represented by diuretics. Neurohormonal agents, usually used in heart failure treatment were avoided, due to poor tolerance and worsening of disease course. The management of these 6 cases was challenging due to the refractory manifestation of congestive heart failure.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes:<\/jats:title>\n                    <jats:p>During follow-up, 4 of the 6 patients from the current study died in the first year after the final diagnosis was established.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Lessons:<\/jats:title>\n                    <jats:p>Nuclear imaging of cardiac amyloidosis has a revolutionary development nowadays. Bone scintigraphy presents promising results for identifying patients at early stages of disease and to differentiate between cardiac amyloidosis types. Further studies are necessary for the standardization of imaging protocol and development of non-invasive diagnostic tools, especially in assessing the response to treatment and disease progression, for which little is known.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000017256","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T23:52:10Z","timestamp":1569887530000},"page":"e17256","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["The role of echocardiography and 99mTc-HDP scintigraphy in non-invasive diagnosis of cardiac amyloidosis"],"prefix":"10.1097","volume":"98","author":[{"given":"Irina Iuliana","family":"Costache","sequence":"first","affiliation":[{"name":"Department of Cardiology, \u201cSt. Spiridon\u201d Emergency Clinical Hospital"},{"name":"University of Medicine and Pharmacy \u201cGrigore T. Popa\u201d"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Buburuz","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cSt. Spiridon\u201d Emergency Clinical Hospital"},{"name":"University of Medicine and Pharmacy \u201cGrigore T. Popa\u201d"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Crisu","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cSt. Spiridon\u201d Emergency Clinical Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Maria","family":"Statescu","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, \u201cSt. Spiridon\u201d Emergency Clinical Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Ungureanu","sequence":"additional","affiliation":[{"name":"University of Medicine and Pharmacy \u201cGrigore T. Popa\u201d"},{"name":"Department of Pathology, \u201cSt. Spiridon\u201d Emergency Clinical Hospital, Iasi, Romania."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Viviana","family":"Aursulesei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, \u201cSt. Spiridon\u201d Emergency Clinical Hospital"},{"name":"University of Medicine and Pharmacy \u201cGrigore T. Popa\u201d"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2019,9]]},"reference":[{"key":"R1-20260519","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3949\/ccjm.84.s3.02","article-title":"Cardiac amyloidosis: an update on diagnosis and treatment","volume":"84","author":"Donnelly","year":"2017","journal-title":"Cleveland Clin J Med"},{"key":"R2-20260519","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12872-015-0043-z","article-title":"Differentiation of infiltrative cardiomyopathy from hypertrophic cardiomyopathy using high-sensitivity cardiac troponin T: a case-control study","volume":"15","author":"Kubo","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"R3-20260519","doi-asserted-by":"crossref","first-page":"e002558","DOI":"10.1161\/CIRCHEARTFAILURE.115.002558","article-title":"Transthyretin cardiac amyloidosis in black Americans","volume":"9","author":"Shah","year":"2016","journal-title":"Circ Heart Fail"},{"key":"R4-20260519","first-page":"1","article-title":"Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)","volume":"00","author":"Damy","year":"2019","journal-title":"Eur Heart J"},{"key":"R5-20260519","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1161\/CIRCRESAHA.117.310982","article-title":"Restrictive cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy","volume":"121","author":"Muchtar","year":"2017","journal-title":"Circ Res"},{"key":"R6-20260519","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.tcm.2017.07.004","article-title":"Cardiac amyloidosis: an update on pathophysiology, diagnosis, and treatment","volume":"28","author":"Siddiqi","year":"2018","journal-title":"Trends Cardiovasc Med"},{"key":"R7-20260519","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12350-013-9803-2","article-title":"Nuclear imaging modalities for cardiac amyloidosis","volume":"21","author":"Bokhari","year":"2014","journal-title":"J Nucl Cardiol"},{"key":"R8-20260519","doi-asserted-by":"crossref","first-page":"e000881","DOI":"10.1136\/openhrt-2018-000881","article-title":"Role of cardiovascular imaging for the diagnosis and prognosis of cardiac amyloidosis","volume":"5","author":"Agha","year":"2018","journal-title":"Open Heart"},{"key":"R9-20260519","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1007\/s12350-015-0261-x","article-title":"Serial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis","volume":"23","author":"Castano","year":"2016","journal-title":"J Nucl Cardiol"},{"key":"R10-20260519","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/CIRCIMAGING.112.000132","article-title":"99mTc-Pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidosis","volume":"6","author":"Bokhari","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"R11-20260519","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.1161\/CIRCULATIONAHA.116.021612","article-title":"Nonbiopsy diagnosis of cardiac transthyretin amyloidosis","volume":"133","author":"Gillmore","year":"2016","journal-title":"Circulation"},{"key":"R12-20260519","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11886-018-0970-2","article-title":"Clinical phenotyping of transthyretin cardiac amyloidosis with bone-seeking radiotracers in heart failure with preserved ejection fraction","volume":"20","author":"Chen","year":"2018","journal-title":"Curr Cardiol Report"},{"key":"R13-20260519","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s12350-017-1028-3","article-title":"Nuclear imaging of cardiac amyloidosis","volume":"26","author":"Andrikopoulou","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R14-20260519","first-page":"1344","article-title":"Prognostic utility of the Perugini grading of 99m Tc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid","volume":"18","author":"Hutt","year":"2017","journal-title":"Eur Heart J"},{"key":"R15-20260519","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10741-014-9463-6","article-title":"Nuclear imaging for cardiac amyloidosis","volume":"20","author":"Noordzij","year":"2015","journal-title":"Heart Fail Rev"},{"key":"R16-20260519","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12872-018-0952-8","article-title":"Diagnosis of cardiac amyloidosis: a systematic review on the role of imaging and biomarkers","volume":"18","author":"Kyriakou","year":"2018","journal-title":"BMC Cardiovasc Disord"},{"key":"R17-20260519","doi-asserted-by":"crossref","first-page":"e000364","DOI":"10.1161\/JAHA.111.000364","article-title":"Updates in cardiac amyloidosis: a review","volume":"1","author":"Banypersad","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"R18-20260519","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4250\/jcvi.2019.27.e9","article-title":"Contemporary imaging diagnosis of cardiac amyloidosis","volume":"27","author":"Lee","year":"2019","journal-title":"J Cardiovasc Imaging"},{"key":"R19-20260519","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1007\/s12350-018-01552-4","article-title":"State-of-the-art radionuclide imaging in cardiac tranthyretin amyloidosis","volume":"26","author":"Sigh","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R20-20260519","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s12350-017-0922-z","article-title":"Accuracy of 99mTc-Hydroxymethylene diphosphonate scintigraphy for diagnosis of transthyretin cardiac amyloidosis","volume":"26","author":"Cappelli","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R21-20260519","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/13506129.2013.871250","article-title":"Bone scintigraphy with 99mtechnetium-hydroxymethylene diphosphonate allows early diagnosis of cardiac involvement in patients with transthyretin-derived systemic amyloidosis","volume":"21","author":"Glaudemans","year":"2014","journal-title":"Amyloid"},{"key":"R22-20260519","article-title":"PYP or DPD and HDP for cardiac amyloidosis one for all, all for one","author":"Cappelli","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R23-20260519","article-title":"Hydroxymethylene diphosphonate for imaging transthyretin cardiac amyloidosis","author":"Lee","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R24-20260519","first-page":"598","article-title":"Early phase 99mTc-HMDP scintigraphy for the diagnosis and typing of cardiac amyloidosis","volume":"10","author":"Galat","year":"2017","journal-title":"JACC"},{"key":"R25-20260519","article-title":"Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scindigraphy","author":"Gallini","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R26-20260519","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s41824-018-0035-1","article-title":"TC-HDP quantitative SPECT\/CT in transthyretin cardiac amyloid and the development of a reference interval for myocardial uptake in the non-affected population","volume":"2","author":"Ramsay","year":"2018","journal-title":"Eur J Hybrid Imaging"},{"key":"R27-20260519","article-title":"Diagnosing cardiac amyloidosis: a wealth of new possibilities with nuclear cardiac imaging","author":"Bullock-Palmer","year":"2019","journal-title":"J Nucl Cardiol"},{"key":"R28-20260519","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1007\/s00259-019-04325-4","article-title":"Time for new imaging and therapeutic approaches in cardiac amyloidosis","volume":"46","author":"Slart","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R29-20260519","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1007\/s00259-019-04290-y","article-title":"Detection of cardiac amyloidosis with 18F-Florbetaben-PET\/CT in comparison to echocardiography, cardiac MRI and DPD-scintigraphy","volume":"46","author":"Kircher","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R30-20260519","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1007\/s00259-018-4013-4","article-title":"Diagnostic accuracy of bone scintigraphy in the assessment of cardiac transthyretin-related amyloidosis: a bivariate meta-analysis","volume":"45","author":"Treglia","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R31-20260519","first-page":"201","article-title":"Amyloidosis \u2013 a rare cause of refractory heart failure in a young female","volume":"58","author":"Costache","year":"2017","journal-title":"Rom J Morphol Embryol"},{"key":"R32-20260519","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"},{"key":"R33-20260519","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1080\/13506120500107162","article-title":"A prospective evaluation of the transthyretin Ile122 allele frequency in an African-American population","volume":"12","author":"Yamashita","year":"2005","journal-title":"Amyloid"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017256","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T16:00:30Z","timestamp":1779206430000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000017256"}},"subtitle":["A case series and literature review"],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":33,"journal-issue":{"issue":"38","published-online":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000017256","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"2019-04-22","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-27","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}